Leboyer M

References (3)

Title : The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder - Kidnapillai_2018_World.J.Biol.Psychiatry__1
Author(s) : Kidnapillai S , Bortolasci CC , Udawela M , Panizzutti B , Spolding B , Connor T , Sanigorski A , Dean OM , Crowley T , Jamain S , Gray L , Scarr E , Leboyer M , Dean B , Berk M , Walder K
Ref : World J Biological Psychiatry , :1 , 2018
PubMedID: 29956574

Title : Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders - Martinez-Martinez_2013_Front.Genet_4_181
Author(s) : Martinez-Martinez P , Molenaar PC , Losen M , Stevens J , Baets MH , Szoke A , Honnorat J , Tamouza R , Leboyer M , Os JV , Rutten BP
Ref : Front Genet , 4 :181 , 2013
PubMedID: 24065983

Title : Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism - Jamain_2003_Nat.Genet_34_27
Author(s) : Jamain S , Quach H , Betancur C , Rastam M , Colineaux C , Gillberg IC , Soderstrom H , Giros B , Leboyer M , Gillberg C , Bourgeron T
Ref : Nat Genet , 34 :27 , 2003
PubMedID: 12669065
Gene_locus related to this paper: human-NLGN2 , human-NLGN4X , human-NLGN4Y , mouse-4neur , human-NLGN3